Exclusive Channel Collaboration AgreementExclusive Channel Collaboration Agreement • November 21st, 2011 • Adeona Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Exclusive Channel Collaboration Agreement (the “Agreement”) is made and entered into effective as of November 18, 2011 (the “Effective Date”) by and between Intrexon Corporation, a Virginia corporation, through its Human Therapeutics Division with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (“Intrexon”), and Adeona Pharmaceuticals, Inc., a Nevada corporation having its principal place of business at 3985 Research Park Drive, Suite 200, Ann Arbor, MI 48108 (“Adeona”). Intrexon and Adeona may be referred to herein individually as a “Party”, and collectively as the “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 21st, 2011 • Adeona Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of ______________, 2011, by and among Adeona Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and Intrexon Corporation, a Virginia corporation (“Intrexon”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 21st, 2011 • Adeona Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
